Inhibitors of S1PR1 are used to treat inflammatory diseases such as multiple sclerosis and IBD, which are diseases that are likely modulated by the lymphatic vasculature (Cartier and Hla, 2019; Oliver et al., 2020). The gene discussed is S1PR1; the disease is inflammatory bowel disease.